Материалов:
1 081 645

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 22

Страница 1 из 3

IMMEDIATE AND LONG-TERM RESULTS OF RADIATION THERAPY IN COMBINATION WITH CAPECITABINE AND OXALIPLATIN IN THE TREATMENT OF PATIENTS WITH ASQUAMOUS CELL CARCINOMA OF THE ANUS chemotherapy regimens with a lower toxicity is the combination of oxaliplatin and capecitabine with RT

АДЪЮВАНТНАЯ ХИМИОТЕРАПИЯ В ЛЕЧЕНИИ БОЛЬНЫХ РАКОМ ЖЕЛЧНОГО ПУЗЫРЯ, gemcitabine, mitomycin, cisplatin, capecitabine, epirubicin, and oxaliplatin. This article provides

Результаты лучевой терапии в сочетании с капецитабином и оксалиплатином в лечении больных плоскоклеточным раком анального канала: непосредственные и отдаленные результаты chemotherapy regimens with a lower toxicity is the combination of oxaliplatin and capecitabine with RT

Клинический случай успешного лечения HER-позитивного диссеминированного рака желудка с полным и продолжительным эффектом with disseminated stomach cancer and HER2/ neu hyperexpression. The combinations of cisplatin+capecitabine

Toxicity analysis during neoadjuvant induction chemotherapy and subsequent chemoradiotherapy in patients with locally advanced gastric cancer of 3D conformal radiotherapy (dose 2 Gy per fraction, total dose 46 Gy) in the setting of capecitabine

Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy, and cyclophosphamide (FAC) or cyclophosphamide, adriamycin, and capecitabine (CAX) between 2007 and 2013. VEGFR2

ASSESSMENT OF THE SAFETY AND FEASIBILITY OF NEOADJUVANT CHEMOTHERAPY (2 CYCLES OF FLOT CHEMOTHERAPY + CHEMORADIOTHERAPY) FOLLOWED BY SURGERY IN THE TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER Gy in daily fractions of 2 Gy) combined with chemotherapy with capecitabine and oxaliplatin

CLINICAL AND MORPHOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY IN A PATIENT WITH LOCALLY ADVANCED GASTRIC CANCER: A CASE REPORT) and chemoradiotherapy (total dose of 46 Gy with the concurrent chemotherapy with capecitabine and oxaliplatin) followed

THE «IN VIVO» STUDY OF BLOOD 5-FLUOROURACIL CONTENT BY QUENCHING OF INTRINSIC PROTEIN FLUORESCENCE

THE «IN VIVO» STUDY OF BLOOD 5-FLUOROURACIL CONTENT BY QUENCHING OF INTRINSIC PROTEIN FLUORESCENCE

Страница 1 из 3